4//SEC Filing
Robichaud Albert 4
Accession 0001562180-20-003221
CIK 0001597553other
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 4:44 PM ET
Size
7.9 KB
Accession
0001562180-20-003221
Insider Transaction Report
Form 4
Robichaud Albert
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-04-28+9,450→ 9,450 totalExercise: $39.87Exp: 2030-04-28→ Common Stock (9,450 underlying)
Footnotes (1)
- [F1]The securities awarded on April 28, 2020 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. 25% of the shares of common stock underlying this stock option award will vest on April 28, 2021, and the remaining 75% of the shares of common stock underlying this stock option award will vest on April 28, 2022, subject, in each case, to the Reporting Person's continued employment with the Issuer on each of the applicable vesting dates.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001612861
Filing Metadata
- Form type
- 4
- Filed
- Apr 29, 8:00 PM ET
- Accepted
- Apr 30, 4:44 PM ET
- Size
- 7.9 KB